Nov 27, 2019
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.03 to $0.01.
The split itself did not change the total investment value.
Telo Genomics Corp. (TDSGF) trades on the Other OTC in the Medical - Diagnostics & Research industry.
Telo Genomics Corp. company overviewThe latest split shown was on November 27, 2019. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records one reverse split, on November 27, 2019.
Already premium? Sign in